|
|
Volumn 3, Issue 5, 2001, Pages 373-382
|
|
Combination lipid-altering therapy: an emerging treatment paradigm for the 21st century.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
NICOTINIC ACID;
CHEMICALLY INDUCED DISORDER;
CORONARY ARTERY DISEASE;
DRUG COMBINATION;
DRUG INTERACTION;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERLIPIDEMIA;
METABOLIC DISORDER;
METABOLISM;
MUSCLE DISEASE;
REVIEW;
RISK FACTOR;
TREATMENT OUTCOME;
ANTILIPEMIC AGENTS;
CORONARY DISEASE;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
HUMANS;
HYPERCHOLESTEROLEMIA;
HYPERLIPIDEMIAS;
METABOLIC DISEASES;
MUSCULAR DISEASES;
NIACIN;
RISK FACTORS;
TREATMENT OUTCOME;
|
|
EID: 0035458781
PISSN: 15233804
EISSN: None
Source Type: Journal
DOI: 10.1007/s11883-001-0075-y Document Type: Review |
|
Times cited : (25)
|
|
References (60)
|
